Cite
HARVARD Citation
Karantanos, T. et al. (2019). Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient Carcinoma. Oncologist. pp. 146-150. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Karantanos, T. et al. (2019). Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient Carcinoma. Oncologist. pp. 146-150. [Online].